Global Trends in Lipoprotein(a) and High-Sensitivity C-Reactive Protein Testing in Patients with Established Atherosclerotic Cardiovascular Disease

Key Points

• To examine global trends in lipoprotein(a) and high-sensitivity C-reactive protein testing in patients with atherosclerotic cardiovascular disease.
• Analysis of testing trends for lipoprotein(a) and C-reactive protein.
• Focus on patients with established atherosclerotic cardiovascular disease.
• Comparison of testing across different regions and demographics.
• Increased testing rates for lipoprotein(a) observed globally.
• High-sensitivity C-reactive protein testing shows variable trends across regions.
• Trends indicate a growing recognition of these biomarkers in cardiovascular risk assessment.